Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Actually it's up 7% already, plus the ask has risen.
Beat you by 9 min...lol
Here's my guess
http://www.viatronix.com/
On The Go Granted Exclusive Partnership With Medical Imaging Technology Leader
Monday August 27, 9:00 am ET
CONCORD, Ontario, Aug. 27 /PRNewswire-FirstCall/ -- On The Go Technologies Group (OTC Bulletin Board: ONGO; 'OTG' 'the Company'), a leading multi- industry computer hardware, software and systems integrator, announced today that the Company has completed negotiations with an industry leader in breakthrough software technology in the field of 2D/3D medical diagnostics, to be their exclusive distribution partner in Canada. OTG will further have access to the product in the United States.
ADVERTISEMENT
The New York based affiliate's pioneering software technology provides physicians a quantum leap in diagnostic tools, both extending lives by enabling non-invasive and accurate visualization for medical problems found within various organs of the body and lowering the net cost of providing health care worldwide.
Their V3D-Colon is the market leader in virtual colonoscopy software. Although colorectal cancer, the second leading cause of cancer related deaths, has a prevention rate of over 90% when pre-cancerous polyps are detected early, an estimated 80-85% of the population is never screened, due in large part to the discomfort, sedation and risk factors of conventional optical colonoscopy. Imaging Economics, one of the industry's most recognized imaging technology journals recently stated in great support of such virtual testing, "Current state-of-the art [screening], including 3D polyp detection and oral contrast tagging, is at least as sensitive as the purported 'gold standard' optical colonoscopy for clinically relevant polyps. In fact, if done right, [we] believe it is the most sensitive test for detecting advanced neoplasia."
The firm's V3D-Calcium Scoring and V3D-Explorer, the firm's the next generation sophisticated technology, is also available for OTG's distribution. Using digital data generated by Computed Tomography (CT), Magnetic Resonance (MRI) and other digital scanners, Viatronix's goal is to provide medical professionals with a means to virtually explore the entirety of the inside the human body, detecting potentially serious abnormalities or disease, extending patients' lives as well as lowering the net cost of providing healthcare worldwide.
CEO Stuart Turk stated, "This partnership is one that puts OTG Healthcare at the forefront, and on the cutting edge, of virtual medical diagnostics. With a growing number of hospitals and clinics adding virtual technology to their testing rounds, not to mention more and more of an aging Baby Boomer generation of patients requesting the non-invasive procedures, the sales potential for the Company in both Canada and the US is a very lucrative one."
It's obvious you are intelligent and have done your homework.
I wish you luck with your investment.
This company has not shown a profit in at least five years that I'm aware of.
They have stated that they do not expect to for at least a year or more.
The management has stated openly that they have little marketing savvy.
They have every intention of issuing an additional 15 million shares in order to generate capitol that should be dilutive to the existing stockholders.
The market has become immune to their press releases that have created more bagholders than samsonite.
The only hope that the high entry shareholders have right now is daytrader momo that might create enough interest to allow them to exit with a percentage of their initial investment. You should thank me for the free advertising.
I promice you that anyone buying in right now falls into three catagories.
1. People averaging down...Bad move in my opinion.
2. Gamblers who like the low share price.
3. Bottom feeders looking for a bounce.
Right now the company is out there marketing shares right now, that's not a great thing. They are behaving like a pinksheet making presentations at investor conferences. They wouldn't have to do that if they were making money
I have done extensive dd on this one and have been following it for at least a year. Yes they do great science. Yes they are in a very large market.
THEY JUST CAN'T MAKE A PROFIT.
It's time for them to put up or shut up. I know how these kind of stocks can move, so I keep watching. It could go to the moon, The train could leave the station so you better get on board. There are a few other pumper phrases I could use but I can't bring them to mind right now.
Trusting these companies is like trusting teenage children, it's dangerous and downright foolish.
I actually bought back in at 1.21 because I thought that it might hold, I was wrong. I sold at 1.12 and guess what, I'm happy. I was taking the price of 1.61 that was available when they released the increation of the shares and felt it would settle at that level. Then Paul gave his little speech and we all found out the retailers had returned product and whoopie, all bets were off. This is a trader stock right now, it's way oversold. It's just that the light at the end of the tunnel is a long way's away. They need to get some bimbo tv star on Ohpra telling all the housefraus how Chromax will make their neighbors husband whistle at them and you won't be able to find a bottle in any Wal-Mart from NY to SanFran. Do you think some heffer mooing her way down the aisle at her local bigbox gives a crap about science? Heck no, She'll buy it if Dr. Phil tells her to though. Quit wasting money paying for studies, and buy some damn commercials NXXI. Ray Charles could see what they need to do. SELL SELL SELL. They put their magic pills out there in almost every vitamin retailer in the country then sat back and patted themselves on the back.
Yeah I'm condescending, I guess I'm not a very nice person. Sorry if I hurt you're feelings, but if you're lookin for nice the market is the wrong place.
If you're gonna tell a story, you should tell the whole story
http://investorshub.advfn.com/boards/read_msg.asp?message_id=22211197
Strickly a bounce play to them, if you don't believe me ask them yourself. I'm the one that brought it to their attention I believe
I was just reading about just how difficult it is now to get private equity financing, credit problems and all. Someone must have seen something here.
Money is real tight now, including mine
500 @ .0055
whoopee $2.75
Q1 earnings filing
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=cfri#getFilings
click the filings tab
This is just an opinion however it is referenced in the letter. One of the reasons for the increase in authorized shares is to allow the current owners to maintain ownership.
The shares could be used to prevent a takeover as an approved issuence could prevent loss of majority.
It was also stated that although there are no current plans to do so the shares could be used as in the past for aquisitions. If issued these shares would have a dilutive effect diminishing the current voting power of existing shares
I received a letter from the company on July 27 2007 informing me of the intent to increase the authorized shares from 500,000,000 to 1,000,000,000.
I could post a link to that letter of intent however that may not be appropriate as it was intended for shareholders, and the public filing really is what counts.
I try to read all the filings.
I would really like to know the actual available float, Are we actually sure that the CEO is selling any of his shares?
From the aforementioned letter
As of the Record Date of July 19, 2007, we had authorized 500,000,000 shares of common stock, of which 171,226,779 shares were issued and outstanding.
Name and Address of Beneficial Owner (1) Common Shares
Beneficially Owned
Percent of
Class (2)
Stuart Turk (3) 222,913,734 56.56%
The Cellular Connection (4) 211,833,400 55.30%
Evan Schwartzberg 200 *
Ralph Magid 200 *
All directors and current executive officers as a group (three people) 222,914,134 56.56%
As filed with the Securities and Exchange Commission on August 14, 2007
Registration No. ____________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
ON THE GO HEALTHCARE, INC.
(Exact name of registrant specified in its charter)
Delaware 98-0231687
(State of other jurisdiction (IRS Employer
of incorporation) Identification Number)
85 Corstate Avenue, Unit #1, Concord, Ontario, Canada L4K 4Y2
(Address of principal executive offices)
ON THE GO HEALTHCARE, INC.
AUGUST 2007 STOCK OPTION PLAN
(Full Title of the Plan)
Stuart Turk, President
85 Corstate Avenue, Unit #1
Concord, Ontario
Canada L4K 4Y2
(905) 760-2987
(Name, address and telephone number of agent for service)
Copies of communications to:
Amy Trombly, Esq.
1320 Centre Street, Suite 202
Newton, MA 02459
(617) 243-0060
CALCULATION OF REGISTRATION FEE
Title of Amount Proposed Maximum Proposed Maximum Amount of
Securities to to be offering Price Registered Aggregate Registration
be Registered Registered(1) per Share(2) offering Price (1) Fee
--------------- ----------- --------------- -------------------- ------------
Common Stock,
$0.001 par value 100,000,000 $ 0.006 $ 600,000 $ $18.42
Comeon folks
companies don't release the details of the purchases they make or the business relationships they develop with providers.
Do you want competetors competeing for goods and services you need to run your business?It's obvious from the wording of the pr that they were not allowed to give the name of the company. Expecting them to be able to give the details of individual relationships is not realistic. Doing that might even make future deals harder to come by. Everyone wants an edge on the competition. I'm just glad that at least we are being kept abreast of progress. Public companies obligations really only go as far as keeping their filings current. And paying taxes of course.
Be Careful
Here's my guess as to who the client is
About Dana Corporation
Dana is a leading supplier of drivetrain, chassis, structural, and engine technologies. Dana people design and manufacture products for every major vehicle and engine producer in the world. Based in Toledo, Ohio, with operations throughout the world, Dana is focused on being an essential partner to automotive, commercial, and off-highway vehicle customers, which collectively produce more than 60 million vehicles annually. The company's continuing operations reported sales of $8.6 billion in 2005. Dana's Internet address is: http://www.dana.com/.
I don't know if it's because I pointed the error out in an email or they caught it themselves.
I believe the date is wrong but what can you do
CFRI Investor Up-date for April 16, 2007
Dear Shareholder,
As part of our on-going commitment to keeping you informed, we are pleased to provide you with this "CFRI Investor Up-Date".
As always, we thank you for the numerous emails and phone calls we have received from Shareholders and interested parties. In order to provide an informative up-date, we have selected the two topics that were most common amongst the majority of emails and calls. Therefore, in this up-date we provide information on the status of the EKO-FLOR Customer Field Trials, and the company's transition to the Nasdaq OTC Bulletin Board.
EKO-FLOR Customer Field Trials
Although we have made announcements as they relate to Customers who have placed orders for EKO-FLOR product to be put into field trials, we would like to take this opportunity to inform our Shareholders that certain other companies have also placed trial orders for EKO-FLOR product. However, at the request of these companies, and to protect the integrity of our business relationships, we have agreed to not make public the names of these customers at this time. We can say that we are extremely confident that the customers who are currently participating in EKO-FLOR field trials represent an outstanding sampling of the industry and it is a privilege to be dealing with each and every one of them on this exciting project.
With regards to trial timing, we have made it known to our customers that they will be in receipt of EKO- FLOR product in September of this year. It is important to note that the length of these field trials will vary by customer. We will do our best to keep Shareholders informed as to our progress during the trials, and we will certainly provide up-dates with regards to the ultimate outcome of each trial.
OTC Bulletin Board Listing
We can report that the audit process is underway and is the final requirement in order for the company to file its Form 10-SB Registration Statement with the Securities and Exchange Commission. Although we had originally targeted this objective to be completed by mid-summer, our timeline for having the Form 10-SB filed is now September. It is our opinion that notwithstanding this delay, our transition to the OTCBB will prove timely for the company based on its current business objectives.
A message from the President & CEO
I would like to take this opportunity to address our information flow to Shareholders. Please know that it has always been the company's policy to not issue press releases unless they are material in nature and they do not interfere with the strategic development of the company, its products or its customers. Press releases designed to trigger short-term, unsustainable activity are of no benefit to Shareholders who have remained loyal to the company while it continues to execute and deliver on its overall business plan. It is my belief that to-date, we have built a solid Shareholder base as well as a significant audience that eagerly monitors the company's progress. As Shareholders, I believe we would all agree that EKO-FLOR orders and contracts following the completion of the customer field trials should be the ultimate catalyst to any significant increases in share value. We have always maintained that the company's business performance will ultimately dictate the true value of our stock. With that in mind, the company is now more confident than ever that it will be rewarded for its hard work and dedication to the task of developing and commercializing our EKO-FLOR composite products.
Sincerely, Marino Kulas
We thank you for your continued support of Conforce.
Sincerely,
Investor Relations
Conforce International, Inc.
--------------------------------------------------------------------------------
email: news@conforce1.com
web: http://www.conforce1.com
You see that is dated April. I was just trying to find something linking the two together. It could mean something, could mean nothing
April 5, 2007 - 9:36 AM EST
IELM 0.024 0.012
IElement Comments On Recent Accomplishments At US Wireless Online
Management Agreement Leads to Significant Growth Opportunities
DALLAS, April 5, 2007 (PRIME NEWSWIRE) -- IElement Corporation (OTCBB:IELM) (Frankfurt:SZQ1) (Frankfurt:IELM), a nationwide provider of advanced communications services and Voice over Internet Protocol (VoIP) solutions, announced today that it has accomplished several significant operational objectives during the first 90 days of its management agreement with US Wireless Online, Inc. (US Wireless) and Sutioc Enterprises, Inc. (Sutioc).
On December 27, 2006, US Wireless and Sutioc (its majority shareholder) entered into an agreement with IElement Corporation whereby IElement began providing integrated customer service, customer management, technical support, network management, accounting, billing, collections and other services for US Wireless.
During the first 90 days of the management agreement IElement was able to dramatically improve operational efficiencies at US Wireless and accomplished a number of operational objectives including: the reduction of US Wireless' telecom vendor accounts from 41 to 7 active vendors; the reduction of monthly telecom vendor expenses by 66% ($360,000 annual savings); the elimination of redundant tower sites; the consolidation and migration of US Wireless' accounting and billing data into one enterprise level system; the migration of US Wireless' customer databases to IElement's CMS platform (a proprietary, fully integrated customer management system); the initiation of 24 x 7 customer support, etc.
"These accomplishments are the first steps toward realizing the full potential of our agreement with US Wireless," commented Ivan Zweig, CEO of IElement Corporation. "While the agreement has already had a significant, positive impact on our revenue, one of the more exciting aspects of the deal is the opportunity to cross sell IElement products and services to the approximately 1,500 new business customers now managed by IElement."
"The majority of these customers are currently only receiving wireless broadband services," continued Zweig. "Now that we have integrated the new customers, improved operations and begun to stabilize the business, we can begin to capitalize on the growth opportunities represented by this new customer base."
IElement is now in the process of launching programs intended to rapidly increase monthly recurring revenue by offering the full suite of IElement products and services across all of the existing wireless broadband markets including Florida, Mississippi, Alabama, Kentucky, Indiana and Pennsylvania. These programs will be accompanied and supported by other sales and market expansion efforts to be announced in the near future.
IELM up 100%
Ogclip
That funniest link on your profile is hilarious
Thanks
0.27 550 OTO 12:09:24
0.26 100 OTO 11:04:42<<<<<<<<This friggin kills me
0.26 2000 OTO 10:30:13
0.26 2000 OTO 10:30:00
I know it might have been part of a completion, Its just funnier to think of it as a trade
Thank you
I hope someone gives um up anyway
I promise you that the bid and ask you are seeing are not accurate. I have a partially executed buy at .0015 that is not being reflected on the bid . It went through at .0015 when the bid was showing .0013, where it's at right now. This is the wild west folks. You'll give um up at .0013, I'll get um at .0015 That 60000 was mine
Great idea selling those 100 @ .26
Feels good to get that weight off your shoulders huh
Forgive me if I'm speaking out of turn here but I hope your not using money for your retirement to invest in pennies
uwrl recovering a little
Nutrition 21 Announces Preliminary Fiscal Year 2007 Results
via COMTEX
August 13, 2007
Company Focused on Building Brands And New Product Introductions
in Fiscal 2008
PURCHASE, N.Y., Aug 13, 2007 (BUSINESS WIRE) --
Nutrition 21, Inc. (NASDAQ: NXXI), a leading developer and marketer of chromium-based and omega-3 fish oil-based nutritional supplements, today announced preliminary financial results for the Company's fiscal year ended June 30, 2007 and provided fiscal year 2008 financial guidance. The audit of the fiscal year 2007 results is not yet completed and these are preliminary results. Nutrition 21 anticipates announcing final audited results on or about September 12, 2007.
Fiscal Year 2007 Full Year Preliminary Unaudited Results
The Company currently anticipates revenues of approximately $42.2 million for fiscal year 2007, an increase of almost 300% when compared to fiscal year 2006 revenues of $10.6 million. Revenues in the fourth quarter were negatively impacted by a $1.8 million return of Selenomax(R) by a national retailer, which had previously made a one-time $2.6 million purchase in the third quarter. Earlier this month, Nutrition 21 entered into an agreement to sell the returned inventory to a third party for $1.7 million in barter credits that the Company expects to use in fiscal 2008.
The Company currently anticipates a net loss for fiscal year 2007 of $18.2 million, or $0.32 per diluted share. The anticipated net loss for the year will include a one-time net charge of $1.4 million in the fourth quarter for the return of Selenomax(R).
In general, the net loss for the year reflects the investments made by the Company to transition from a research and development-focused company selling chromium picolinate as an ingredient, to a sales and marketing-driven company selling branded consumer product goods targeting significant and growing age- and weight- related health needs, including diabetes, cardiovascular health, obesity, joint health, cognitive function and mental health.
The activities and investments during the fiscal year included:
-- Adding key members to our retail sales, marketing and distribution team;
-- Conducting pre-market activities associated with launching Chromax(R), Iceland Health Omega-3(R), Iceland Health Joint Relief(R) and Diachrome(R) into the retail channel. Such activities include market research, focus groups, web site development, collateral development, as well as developing integrated marketing programs, such as PR, print and radio advertisements;
-- Acquiring Iceland Health, Inc. on August 25, 2006 and integrating its established line of Omega-3 products that promote cardiovascular and joint health. The acquisition also provided us with direct-to-consumer marketing and sales capabilities, which allow us to effectively leverage television infomercials, print, radio, direct mail, and Internet e-commerce;
-- Expanding the Company's direct response operations by adding new call centers, developing new marketing and sales programs in Spanish, producing and launching a 30-minute infomercial for Chromax(R) and developing line extensions for the Iceland Health franchise that will launch in Fall 2007;
-- Testing and refining radio and print media campaigns for the four products that Nutrition 21 currently sells at retail, and financing national retail radio and print campaigns to advertise both Chromax(R) in the third quarter of fiscal 2007 and Iceland Health products introduced at retail in the fourth quarter of fiscal 2007;
-- Completing research and development for Advanced Memory Formula(TM), a nutritional supplement for promoting cognitive function. The Company recently completed a randomized-double-blind, placebo-controlled, clinical trial evaluating recall performance and brain activity using MRI scans. Nutrition 21 filed a patent covering this product ; and
-- Preparing for the Fall 2007 launches of Advanced Memory Formula(TM) and Diabetes Essentials(R), a line of nutritional supplements for people with type-2 diabetes. Major retailers and key regional retailers have already placed purchase orders for both products.
Paul Intlekofer, Nutrition 21's President and Chief Executive Officer, said, "In this past year we made significant progress towards our goal of becoming a leading nutritional supplements company with premium branded products. Our increased momentum is reflected by the following:
-- We began the fiscal year with 4 shelf keeping units (SKUs) at retail, ended the fiscal year with 10, and have commitments in place to expand to 14 by the Fall of 2007;
-- The chromium category grew by 37.1% in the drug channel, and Chromax(R) became the #1 selling chromium brand at retail;
-- Chromium picolinate was incorporated as an ingredient into Ross/Abbott's Glucerna, the leading diabetes nutrition shake, Coca-Cola, Minute Maid Multi and, in the past month, a newly launched Diet Coke;
-- Iceland Health direct response sales grew 15% on an annualized basis since its acquisition in August 2006; and
-- Sales of Chromax1000(R) through an initial infomercial program reached a weekly high of $60,000 in the second month of this program in the first week of July.
Intlekofer concluded, "We now have a diverse portfolio of best-in-class products, extensive marketing capabilities, strong relationships with our retail distributors and an experienced staff. Excluding the one-time sale and return of Selenomax(R), we have grown sales in each of the last four quarters. The investments we made during this past year have enabled us to build our brands and have positioned us to be able to generate sustainable growth over the next few years."
Management's Current Expectations for the Fiscal Year Ending June 30, 2008
Nutrition 21 expects revenue for fiscal year 2008 to be in the range of approximately $70 to $80 million, a 66% to 94% increase over our preliminary estimates for fiscal 2007 revenue. These expectations reflect management's current view. Actual results may differ depending upon the success of our new product launches, various marketing initiatives and other factors.
Yep it sure is
NXXI may get the shove over the cliff today it needs to become of interest
Man that one is all over the place very few shares available after the uplist
Look nbs again
I'm looking at NINE for something this week
Recently fell off the cliff
http://stockcharts.com/h-sc/ui?s=NINE&p=D&b=5&g=0&id=p80530432297
Earnings out Friday according to scottrade, I'm not sure about that
Cute, real cute...LOL
About Equity Stock Analysis
EQUITY STOCK ANALYSIS ("ESA") is committed to the highest ethical standards and as such is not subject to external pressure that is sometimes experienced to issue biased research. This pressure is avoided by refusing to accept companies that cannot be recommended with objectivity, quality, and accuracy of research. ESA and its Certified Financial Analysts are independent, objective, and have a reasonable and adequate basis for our investment recommendations. ESA has established formal written policies supporting independent and objective analyst research. ESA has senior corporate officer publicly attest, at least annually, to adherence to the policy.
This new partnership with a SEWP preferred vendor and prime contractor Technica Corporation will bring business to ONGO without advertising or increased sales intiatives. It is my understanding that this network is the vehicle that government agencies and their clientele use to locate and obtain IT products and product solutions. The amount of business it could bring to the company without the usual costs associated with sales is exciting. Agencies will come to them instead of them pounding the pavement or the phones for sales. I believe the exposure of the company may also be increased in the United States. When was the last time you were in a Federal Agency when the first thing you were confronted with wasn't a person behind a terminal?
I'm trying to think past next weeks pps
Look at NBS now
Solutions for Enterprise Wide Procurement
http://sewp.nasa.gov/
I'm watching NBS. Neostem
Just uplisted to AMEX yesterday after a 1 to 10 split
Price is dropping I'm watching